Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial

BACKGROUND: Animal and cellular studies support the importance of autophagy inhibition in lymphangioleiomyomatosis (LAM). In a cohort of subjects with LAM, we tested the hypothesis that treatment with sirolimus and hydroxychloroquine (an autophagy inhibitor) at two different dose levels is safe and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Chest
Main Authors: El-Chemaly, Souheil, Taveira-Dasilva, Angelo, Goldberg, Hilary J., Peters, Elizabeth, Haughey, Mary, Bienfang, Don, Jones, Amanda M., Julien-Williams, Patricia, Cui, Ye, Villalba, Julian A., Bagwe, Shefali, Maurer, Rie, Rosas, Ivan O., Moss, Joel, Henske, Elizabeth P.
Format: Artigo
Sprog:Inglês
Udgivet: American College of Chest Physicians 2017
Fag:
Diffuse Lung Disease
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026235/
https://ncbi.nlm.nih.gov/pubmed/28192114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2017.01.033
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker